Skip to main content
Erschienen in: Current Obstetrics and Gynecology Reports 4/2014

01.12.2014 | Management of Menopause (K-E Huang, Section Editor)

Primary Ovarian Insufficiency

verfasst von: Rodney J. Baber, Michele Kwik

Erschienen in: Current Obstetrics and Gynecology Reports | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Primary ovarian insufficiency (POI) is a syndrome of amenorrhoea, sex steroid deficiency, and elevated gonadotropins in a woman aged more than two standard deviations below the mean age for menopause estimated for her reference population. In practical terms, it occurs spontaneously in 1 % of women before the age of 40 years. Apart from idiopathic POI, many women will have impaired ovarian function by age 40 years as a consequence of surgery, chemotherapy, or radiotherapy. Of identifiable causes of POI, the most common are concurrent autoimmune diseases such as thyroid and adrenal disease, and chromosomal abnormalities such as Turner syndrome and Fragile X syndrome. Women with POI have an increased risk of heart disease, osteoporosis, stroke, cognitive impairment, and premature death. These risks appear to be greater following a surgical menopause. POI is associated with an increased prevalence of anxiety, depression, and loss of self-esteem. Whilst most women with POI will remain infertile following their diagnosis, many will menstruate again and 5 – 10 % will become pregnant. The keys to good management are a multidisciplinary approach, careful long-term follow–up, and appropriate use of hormone replacement therapy.
Literatur
2.
Zurück zum Zitat Coulam CB et al. Empty follicle syndrome. Fertil Steril. 1986;46:1153–5.PubMed Coulam CB et al. Empty follicle syndrome. Fertil Steril. 1986;46:1153–5.PubMed
3.•
Zurück zum Zitat Cooper AR et al. The time is now for a new approach to primary ovarian insufficiency. Fertil Steril. 2011;95:1890–7. This article is a good summary on POI.PubMedCentralPubMedCrossRef Cooper AR et al. The time is now for a new approach to primary ovarian insufficiency. Fertil Steril. 2011;95:1890–7. This article is a good summary on POI.PubMedCentralPubMedCrossRef
5.•
Zurück zum Zitat Rafique S et al. A new approach to primary ovarian insufficiency. Obstet Gynecol Clin N Am. 2012;39:567–86. This article is a good summary on POI.CrossRef Rafique S et al. A new approach to primary ovarian insufficiency. Obstet Gynecol Clin N Am. 2012;39:567–86. This article is a good summary on POI.CrossRef
6.
Zurück zum Zitat Persani L et al. Genes involved in human premature ovarian failure. J Mol Endocrinol. 2010;45:257–79.PubMedCrossRef Persani L et al. Genes involved in human premature ovarian failure. J Mol Endocrinol. 2010;45:257–79.PubMedCrossRef
8.•
Zurück zum Zitat Cox L, Liu J. Primary ovarian insufficiency; and update. Int J Women's Health. 2014;6:235–43. This article is a good summary on POI. Cox L, Liu J. Primary ovarian insufficiency; and update. Int J Women's Health. 2014;6:235–43. This article is a good summary on POI.
9.
Zurück zum Zitat Cate RL et al. Isolation of bovine and human genes for mullerian inhibiting substance and expression of the human gene in animal cells. Cell. 1986;45:685–98.PubMedCrossRef Cate RL et al. Isolation of bovine and human genes for mullerian inhibiting substance and expression of the human gene in animal cells. Cell. 1986;45:685–98.PubMedCrossRef
10.
Zurück zum Zitat Kevenaar ME et al. Serum AMH levels reflect the size of the primordial follicle pool in mice. Endocrinology. 2006;147:3228–34.PubMedCrossRef Kevenaar ME et al. Serum AMH levels reflect the size of the primordial follicle pool in mice. Endocrinology. 2006;147:3228–34.PubMedCrossRef
11.•
Zurück zum Zitat Dewailly D et al. The physiology and clinical utility of AMH in women. Hum Reprod Update. 2014;20:370–85. This article is a good summary on AMH and its clinical application.PubMedCrossRef Dewailly D et al. The physiology and clinical utility of AMH in women. Hum Reprod Update. 2014;20:370–85. This article is a good summary on AMH and its clinical application.PubMedCrossRef
12.
Zurück zum Zitat Dillon K et al. Pretreatment levels of AMH determine post therapy rates of recovery of ovarian reserve in women undergoing chemotherapy. Fertil Steril. 2013;99:477–83.PubMedCentralPubMedCrossRef Dillon K et al. Pretreatment levels of AMH determine post therapy rates of recovery of ovarian reserve in women undergoing chemotherapy. Fertil Steril. 2013;99:477–83.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Dolleman M et al. AMH is a more accurate predictor of an individual's time to menopause than mother’s age at menopause. Hum Reprod. 2014;29:584–91.PubMedCrossRef Dolleman M et al. AMH is a more accurate predictor of an individual's time to menopause than mother’s age at menopause. Hum Reprod. 2014;29:584–91.PubMedCrossRef
14.
Zurück zum Zitat Sklavos MM et al. AMH deficiency in females with Fanconi anaemia. J Clin Endocrinol Metab. 2014;99(5):1608–14.PubMedCrossRef Sklavos MM et al. AMH deficiency in females with Fanconi anaemia. J Clin Endocrinol Metab. 2014;99(5):1608–14.PubMedCrossRef
15.
Zurück zum Zitat Spencer JB et al. Modifiers of ovarian function in girls and young women with classic galactosemia. J Clin Endocrinol Metab. 2013;98:1257–65.CrossRef Spencer JB et al. Modifiers of ovarian function in girls and young women with classic galactosemia. J Clin Endocrinol Metab. 2013;98:1257–65.CrossRef
17.
Zurück zum Zitat Sybert V, McCauley E. Turner syndrome. N Engl J Med. 2004;351:127–38.CrossRef Sybert V, McCauley E. Turner syndrome. N Engl J Med. 2004;351:127–38.CrossRef
18.
Zurück zum Zitat Allen EG et al. Examination of reproductive milestones amongst women who carry the FMR1 pre mutation. Hum Reprod. 2007;22:2142–52.PubMedCrossRef Allen EG et al. Examination of reproductive milestones amongst women who carry the FMR1 pre mutation. Hum Reprod. 2007;22:2142–52.PubMedCrossRef
19.
Zurück zum Zitat Willemsen R et al. CGG repeats in the FMR 1 pre mutation. Size Matter Clin Genet. 2011;0:214–25.CrossRef Willemsen R et al. CGG repeats in the FMR 1 pre mutation. Size Matter Clin Genet. 2011;0:214–25.CrossRef
20.
21.
22.
Zurück zum Zitat Waad-Allah S et al. CAH due to 17 alpha hydroxylase deficiency. Oman Med J. 2014;29:55–9.CrossRef Waad-Allah S et al. CAH due to 17 alpha hydroxylase deficiency. Oman Med J. 2014;29:55–9.CrossRef
25.
Zurück zum Zitat Conway G et al. Characterisation of idiopathic premature ovarian failure. Fertil Steril. 1996;65:337–14.PubMed Conway G et al. Characterisation of idiopathic premature ovarian failure. Fertil Steril. 1996;65:337–14.PubMed
26.
Zurück zum Zitat Alper M, Garner P. Premature ovarian failure: its relationship to autoimmune disease. Obstet Gynecol. 1985;66:27–30.PubMed Alper M, Garner P. Premature ovarian failure: its relationship to autoimmune disease. Obstet Gynecol. 1985;66:27–30.PubMed
27.
Zurück zum Zitat Rebar R. Mechanisms of premature menopause. Endocrinol Metab Clin N Am. 2005;34:923–33.CrossRef Rebar R. Mechanisms of premature menopause. Endocrinol Metab Clin N Am. 2005;34:923–33.CrossRef
28.
Zurück zum Zitat Kokcu A. Premature ovarian failure from a current perspective. Gynecol Endocrinol. 2010;26:555–62.PubMedCrossRef Kokcu A. Premature ovarian failure from a current perspective. Gynecol Endocrinol. 2010;26:555–62.PubMedCrossRef
29.
Zurück zum Zitat Ohl J et al. Alterations in ovarian reserve tests in HIV infected women. Gynecol Obstet Fertil. 2010;38:313–7.PubMedCrossRef Ohl J et al. Alterations in ovarian reserve tests in HIV infected women. Gynecol Obstet Fertil. 2010;38:313–7.PubMedCrossRef
30.
Zurück zum Zitat Siddle N et al. The effect of hysterectomy on age at ovarian failure. Fertil Steril. 1987;47:94–100.PubMed Siddle N et al. The effect of hysterectomy on age at ovarian failure. Fertil Steril. 1987;47:94–100.PubMed
32.
33.
Zurück zum Zitat Busacca M et al. Post surgical ovarian failure after laparoscopic removal of endometriomas. Am J Obstet Gynecol. 2006;195:421–5.PubMedCrossRef Busacca M et al. Post surgical ovarian failure after laparoscopic removal of endometriomas. Am J Obstet Gynecol. 2006;195:421–5.PubMedCrossRef
34.
Zurück zum Zitat Raffi F et al. The impact of removal of ovarian endometrioma on ovarian reserve. J Clin Endocrinol Metab. 2012;97:3146–54.PubMedCrossRef Raffi F et al. The impact of removal of ovarian endometrioma on ovarian reserve. J Clin Endocrinol Metab. 2012;97:3146–54.PubMedCrossRef
35.
Zurück zum Zitat Bjelland EK et al. Is unilateral oophorectomy associated with age at menopause? Hum Reprod. 2014;29:835–41.PubMedCrossRef Bjelland EK et al. Is unilateral oophorectomy associated with age at menopause? Hum Reprod. 2014;29:835–41.PubMedCrossRef
36.•
Zurück zum Zitat Baber R. Primary ovarian insufficiency. Med Today. 2014;15:73–5. This article is a good summary on POI. Baber R. Primary ovarian insufficiency. Med Today. 2014;15:73–5. This article is a good summary on POI.
37.•
Zurück zum Zitat Fleischer RT et al. The effect of chemotherapy and radiotherapy on fertility in premenopausal women. Obstet Gynecol Surv. 2011;66:248–54. This article is a good summary on the effect of chemoradiation therapy on fertility.PubMedCrossRef Fleischer RT et al. The effect of chemotherapy and radiotherapy on fertility in premenopausal women. Obstet Gynecol Surv. 2011;66:248–54. This article is a good summary on the effect of chemoradiation therapy on fertility.PubMedCrossRef
38.
Zurück zum Zitat Barameh S et al. Ovarian transposition prior to pelvic irradiation. J Obstet Gynaecol Res. 2013;39:1533–7.CrossRef Barameh S et al. Ovarian transposition prior to pelvic irradiation. J Obstet Gynaecol Res. 2013;39:1533–7.CrossRef
39.
Zurück zum Zitat Constine LS et al. Hypothalamic pituitary dysfunction after irradiation for brain tumours. N Engl J Med. 1993;328:87–94.PubMedCrossRef Constine LS et al. Hypothalamic pituitary dysfunction after irradiation for brain tumours. N Engl J Med. 1993;328:87–94.PubMedCrossRef
40.
Zurück zum Zitat Maltaris T et al. The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol. 2007;130:148–55.PubMedCrossRef Maltaris T et al. The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol. 2007;130:148–55.PubMedCrossRef
41.
Zurück zum Zitat Wallace WH et al. Fertility preservation for young people with cancer; who is at risk and what can be offered. Lancet Oncol. 2005;6:209–18.PubMedCrossRef Wallace WH et al. Fertility preservation for young people with cancer; who is at risk and what can be offered. Lancet Oncol. 2005;6:209–18.PubMedCrossRef
43.
Zurück zum Zitat Richardson RB et al. Greater organ involution in highly proliferative tissues is associated with the early onset of and accelerated ageing in humans. Exp Gerontol. 2014;55:80–91.PubMedCrossRef Richardson RB et al. Greater organ involution in highly proliferative tissues is associated with the early onset of and accelerated ageing in humans. Exp Gerontol. 2014;55:80–91.PubMedCrossRef
44.
Zurück zum Zitat Alzubaidi NHH et al. Meeting the needs of your women with secondary amenorrhoea and premature ovarian failure. Obstet Gynecol. 2002;99:720–5.PubMedCrossRef Alzubaidi NHH et al. Meeting the needs of your women with secondary amenorrhoea and premature ovarian failure. Obstet Gynecol. 2002;99:720–5.PubMedCrossRef
45.
Zurück zum Zitat Schmidt PJ et al. Shyness, social anxiety and impaired self esteem in women with turner syndrome and POI. JAMA. 2006;295:1374–6.PubMedCrossRef Schmidt PJ et al. Shyness, social anxiety and impaired self esteem in women with turner syndrome and POI. JAMA. 2006;295:1374–6.PubMedCrossRef
46.
Zurück zum Zitat Van Kasteren Y, Shoemaker J. Premature ovarian failure. A systematic review of therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update. 1999;5:483–92.PubMedCrossRef Van Kasteren Y, Shoemaker J. Premature ovarian failure. A systematic review of therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update. 1999;5:483–92.PubMedCrossRef
47.
Zurück zum Zitat Alper MM et al. Pregnancies after premature ovarian failure. Obstet Gynecol. 1986;67:59S–62.PubMedCrossRef Alper MM et al. Pregnancies after premature ovarian failure. Obstet Gynecol. 1986;67:59S–62.PubMedCrossRef
48.
Zurück zum Zitat Baker V. Life plans and family building options for women with POI. Semin Reprod Med. 2011;29:362–72.PubMedCrossRef Baker V. Life plans and family building options for women with POI. Semin Reprod Med. 2011;29:362–72.PubMedCrossRef
49.
Zurück zum Zitat Ben-Nagy J, Panay N. Premature ovarian insufficiency: how to improve reproductive outcome? Climacteric. 2014;17(3):242–6.CrossRef Ben-Nagy J, Panay N. Premature ovarian insufficiency: how to improve reproductive outcome? Climacteric. 2014;17(3):242–6.CrossRef
50.•
Zurück zum Zitat The Practice Committee of the American Society of Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2013;100:1214–23. This article is a good reference for fertility preservation strategies.CrossRef The Practice Committee of the American Society of Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2013;100:1214–23. This article is a good reference for fertility preservation strategies.CrossRef
51.
Zurück zum Zitat Garcia-Velasco J. Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos. Fertil Steril. 2012;97:527–8.PubMedCrossRef Garcia-Velasco J. Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos. Fertil Steril. 2012;97:527–8.PubMedCrossRef
52.
Zurück zum Zitat Cobo A et al. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod. 2010;25:2239–46.PubMedCrossRef Cobo A et al. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod. 2010;25:2239–46.PubMedCrossRef
53.
Zurück zum Zitat Henderson VW, Sherwin BB. Surgical versus natural menopause: cognitive issues. Menopause. 2007;14:572–9.PubMedCrossRef Henderson VW, Sherwin BB. Surgical versus natural menopause: cognitive issues. Menopause. 2007;14:572–9.PubMedCrossRef
55.
Zurück zum Zitat Bove R et al. Age at surgical menopause influences cognitive decline and Alzheimers pathology in older women. Neurology. 2014;21:222–9.CrossRef Bove R et al. Age at surgical menopause influences cognitive decline and Alzheimers pathology in older women. Neurology. 2014;21:222–9.CrossRef
56.
Zurück zum Zitat Rocca W et al. Oophorectomy, menopause, estrogen treatment and cognitive ageing. Clinical evidence for a window of opportunity. Brain Res. 2011;16:188–98.CrossRef Rocca W et al. Oophorectomy, menopause, estrogen treatment and cognitive ageing. Clinical evidence for a window of opportunity. Brain Res. 2011;16:188–98.CrossRef
57.
Zurück zum Zitat Ossewarde M et al. Age at menopause, cause specific mortality and total life expectancy. Epidemiology. 2005;16:556–62.CrossRef Ossewarde M et al. Age at menopause, cause specific mortality and total life expectancy. Epidemiology. 2005;16:556–62.CrossRef
58.
Zurück zum Zitat Mondul A et al. Age at natural menopause and cause specific mortality. Am J Epidemiol. 2005;162:1089–97.PubMedCrossRef Mondul A et al. Age at natural menopause and cause specific mortality. Am J Epidemiol. 2005;162:1089–97.PubMedCrossRef
59.•
Zurück zum Zitat Wellons M et al. Early menopause predicts increased risk of coronary heart disease and stroke. Menopause. 2012;19:1081–7. This article is a good reference for POI and cardiovascular disease.PubMedCentralPubMedCrossRef Wellons M et al. Early menopause predicts increased risk of coronary heart disease and stroke. Menopause. 2012;19:1081–7. This article is a good reference for POI and cardiovascular disease.PubMedCentralPubMedCrossRef
60.
Zurück zum Zitat Atsma F et al. Post menopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006;13:265–79.PubMedCrossRef Atsma F et al. Post menopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006;13:265–79.PubMedCrossRef
62.•
Zurück zum Zitat Rocca W et al. Premature menopause or early menopause and risk of stroke. Menopause. 2012;19:272–7. This article is a good reference for POI and stroke.PubMedCentralPubMedCrossRef Rocca W et al. Premature menopause or early menopause and risk of stroke. Menopause. 2012;19:272–7. This article is a good reference for POI and stroke.PubMedCentralPubMedCrossRef
63.
Zurück zum Zitat Anasti JN et al. Bone loss in young women with karyotypically normal premature ovarian failure. Obstet Gynecol. 1998;91:12–5.PubMedCrossRef Anasti JN et al. Bone loss in young women with karyotypically normal premature ovarian failure. Obstet Gynecol. 1998;91:12–5.PubMedCrossRef
64.
Zurück zum Zitat Pal L, Santoro N. Premature ovarian failure: discordance between somatic and reproductive ageing. Ageing Res Rev. 2002;1:413–23.PubMedCrossRef Pal L, Santoro N. Premature ovarian failure: discordance between somatic and reproductive ageing. Ageing Res Rev. 2002;1:413–23.PubMedCrossRef
65.
Zurück zum Zitat Luborsky JL et al. Premature menopause in a multiethnic study of the menopause transition. Hum Reprod. 2002;18:199–206.CrossRef Luborsky JL et al. Premature menopause in a multiethnic study of the menopause transition. Hum Reprod. 2002;18:199–206.CrossRef
66.
Zurück zum Zitat Shuster L et al. Prophylactic oophorectomy in premenopausal women and long term health - a review. Menopause Int. 2008;14:111–6.PubMedCentralPubMed Shuster L et al. Prophylactic oophorectomy in premenopausal women and long term health - a review. Menopause Int. 2008;14:111–6.PubMedCentralPubMed
67.
Zurück zum Zitat Greil A. Infertility and psychological stress: a critical review. Soc Sci Med. 1997;45:1679–704.PubMedCrossRef Greil A. Infertility and psychological stress: a critical review. Soc Sci Med. 1997;45:1679–704.PubMedCrossRef
68.
Zurück zum Zitat Mishell DR et al. Serum gonadotropin and steroid patterns during the normal menstrual cycle. Am J Obstet Gynecol. 1971;111:60–5.PubMed Mishell DR et al. Serum gonadotropin and steroid patterns during the normal menstrual cycle. Am J Obstet Gynecol. 1971;111:60–5.PubMed
69.
Zurück zum Zitat Scarabin P et al. Differential association of oral and transdermal estrogen therapy with venous thromboembolism risk. Lancet. 2003;362:428–32.PubMedCrossRef Scarabin P et al. Differential association of oral and transdermal estrogen therapy with venous thromboembolism risk. Lancet. 2003;362:428–32.PubMedCrossRef
70.
Zurück zum Zitat Gibbons WR et al. Biochemical and histological effects of estrogen and progestogen therapy on the endometrium of postmenopausal women. Am J Obstet Gynecol. 1986;154:456–61.PubMedCrossRef Gibbons WR et al. Biochemical and histological effects of estrogen and progestogen therapy on the endometrium of postmenopausal women. Am J Obstet Gynecol. 1986;154:456–61.PubMedCrossRef
71.
Zurück zum Zitat Fournier A et al. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107:103–11.PubMedCentralPubMedCrossRef Fournier A et al. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107:103–11.PubMedCentralPubMedCrossRef
72.
Zurück zum Zitat Rossouw J et al. Risks and benefits of estrogen plus progestin in health post menopausal women: principal results from the Women's Health Initiative RCT. JAMA. 2002;288:321–33.PubMedCrossRef Rossouw J et al. Risks and benefits of estrogen plus progestin in health post menopausal women: principal results from the Women's Health Initiative RCT. JAMA. 2002;288:321–33.PubMedCrossRef
73.•
Zurück zum Zitat de Villiers T et al. Global consensus statement on menopausal hormone therapy. Climacteric. 2013;16:203–4. This article is a good reference for hormone replacement therapy.PubMedCrossRef de Villiers T et al. Global consensus statement on menopausal hormone therapy. Climacteric. 2013;16:203–4. This article is a good reference for hormone replacement therapy.PubMedCrossRef
74.
Zurück zum Zitat Davis SR, Burger HG. The role of androgen therapy. Best Pract Res Clin Endocrinol Metab. 2003;17:165–75.PubMedCrossRef Davis SR, Burger HG. The role of androgen therapy. Best Pract Res Clin Endocrinol Metab. 2003;17:165–75.PubMedCrossRef
75.
Zurück zum Zitat Kalantaridou S et al. Testosterone deficiency in young women with 46XX premature ovarian failure. Fertil Steril. 2006;86:1475–82.PubMedCrossRef Kalantaridou S et al. Testosterone deficiency in young women with 46XX premature ovarian failure. Fertil Steril. 2006;86:1475–82.PubMedCrossRef
76.
Zurück zum Zitat Guerrieri GM et al. Effects of physiological testosterone therapy on quality of life, self esteem and mood in women with premature ovarian insufficiency. Menopause. 2014;21:1–9.CrossRef Guerrieri GM et al. Effects of physiological testosterone therapy on quality of life, self esteem and mood in women with premature ovarian insufficiency. Menopause. 2014;21:1–9.CrossRef
77.
Zurück zum Zitat Davis SR, Worsley R. Androgen treatment of post menopausal women. J Steroid Biochem Mol Biol. 2014;142:107–14.PubMedCrossRef Davis SR, Worsley R. Androgen treatment of post menopausal women. J Steroid Biochem Mol Biol. 2014;142:107–14.PubMedCrossRef
78.
Zurück zum Zitat Baber R, Kwik M. Therapy for menopausal symptoms during and after breast cancer: safety considerations. Drug Saf. 2005;28:1085–2000.PubMedCrossRef Baber R, Kwik M. Therapy for menopausal symptoms during and after breast cancer: safety considerations. Drug Saf. 2005;28:1085–2000.PubMedCrossRef
79.
Metadaten
Titel
Primary Ovarian Insufficiency
verfasst von
Rodney J. Baber
Michele Kwik
Publikationsdatum
01.12.2014
Verlag
Springer US
Erschienen in
Current Obstetrics and Gynecology Reports / Ausgabe 4/2014
Elektronische ISSN: 2161-3303
DOI
https://doi.org/10.1007/s13669-014-0094-7

Weitere Artikel der Ausgabe 4/2014

Current Obstetrics and Gynecology Reports 4/2014 Zur Ausgabe

Management of Menopause (K-E Huang, Section Editor)

How to Prescribe MHT According to the Risk of Breast Cancer

Management of Menopause (K-E Huang, Section Editor)

Menopausal Hormonal Therapy and Cardiovascular Disease

Minimally Invasive Gynecologic Surgery (A Fader, Section Editor)

Update on Robotic Versus Laparoscopic Sacrocolpopexy: Outcomes and Costs

Minimally Invasive Gynecologic Surgery (A Fader, Section Editor)

Robotic Surgery in Gynecologic Oncology: Updates and Innovations

Management of Menopause (K-E Huang, Section Editor)

DHEA supplementation in Menopause

Minimally Invasive Gynecologic Surgery (A Fader, Section Editor)

Laparoscopic Management of Pelvic Masses in Pregnancy

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.